Cipla Shares Rally 9% After Q1 Results; Should You Buy, Sell or Hold The Pharma Stock? –…
Cipla shares climbed 9 per cent in Thursday’s trade on Thursday after the pharma company reported robust earnings for the first quarter of FY24. US revenues for Q1 were the highest ever. Despite limited period gRevlimid cash flow, Cipla has…